Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HLA-DRβ1-Arg74 refers to a specific variant of the HLA-DRβ1 protein, characterized by an arginine at position 74. This variant is associated with increased risk for several autoimmune diseases, including type 1 diabetes, autoimmune thyroid disease, Graves' disease, and Hashimoto's thyroiditis. It plays a critical role in antigen presentation and immune response regulation by influencing peptide binding properties. Targeting this molecule with compounds like cepharanthine may offer therapeutic benefits by blocking harmful autoimmune responses.
Blocking peptide binding and presentation to T-cells, potentially reducing autoimmune responses.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HLA-DRβ1 Protein Containing Arginine at Position 74 (HLA-DRβ1-Arg74).